110 related articles for article (PubMed ID: 6407957)
1. Cell-free translation of human liver apolipoprotein AI and AII mRNA. Processing of primary translation products.
Stoffel W; Krüger E; Deutzmann R
Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):227-37. PubMed ID: 6407957
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and processing of human serum apolipoprotein AII in vitro and in Hep G2 cells.
Stoffel W; Blau R; Burk M
Biol Chem Hoppe Seyler; 1985 Feb; 366(2):173-9. PubMed ID: 2985098
[TBL] [Abstract][Full Text] [Related]
3. Expression of the human serum apolipoprotein AI and AII genes in Xenopus laevis oocytes. Lipid-associated secretion of gene products.
Haase A; Stoffel W
Biol Chem Hoppe Seyler; 1988 Jul; 369(7):585-93. PubMed ID: 2852015
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing and compartmentalization of the primary translation products of mammalian apolipoprotein mRNAs.
Gordon JI; Sims HF; Strauss AW; Scanu AM; Edelstein C; Byrne RE
CRC Crit Rev Biochem; 1986; 20(1):37-71. PubMed ID: 3514123
[TBL] [Abstract][Full Text] [Related]
5. Albumin inhibits apolipoprotein AI and AII production in human hepatoblastoma cell line (Hep G2): additive effects of oleate-albumin complex.
Sakai T; Jin FY; Kamanna VS; Kashyap ML
Atherosclerosis; 2000 Mar; 149(1):43-9. PubMed ID: 10704613
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements of human preproapolipoprotein AI for translocation and processing studied by site-directed mutagenesis in vitro.
Stoffel W; Binczek E
Biol Chem Hoppe Seyler; 1988 Sep; 369(9):1055-63. PubMed ID: 3228490
[TBL] [Abstract][Full Text] [Related]
7. Effect of acute inflammation on rat apolipoprotein mRNA levels.
Tu GF; De Jong F; Apostolopoulos J; Nagashima M; Fidge N; Schreiber G; Howlett G
Inflammation; 1987 Jun; 11(2):241-51. PubMed ID: 3108158
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, transport, and processing of apolipoproteins of high density lipoproteins.
Stoffel W
J Lipid Res; 1984 Dec; 25(13):1586-92. PubMed ID: 6442339
[TBL] [Abstract][Full Text] [Related]
9. The C-terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high-density lipoproteins.
Lambert G; Decout A; Vanloo B; Rouy D; Duverger N; Kalopissis A; Vandekerckhove J; Chambaz J; Brasseur R; Rosseneu M
Eur J Biochem; 1998 Apr; 253(1):328-38. PubMed ID: 9578492
[TBL] [Abstract][Full Text] [Related]
10. Serum apolipoprotein AI synthesis in rat hepatocytes and its secretion as proform.
Stoffel W; Bode C; Knyrim K
Hoppe Seylers Z Physiol Chem; 1983 Apr; 364(4):439-45. PubMed ID: 6407959
[TBL] [Abstract][Full Text] [Related]
11. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
[TBL] [Abstract][Full Text] [Related]
13. Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance.
Sharpe CR; Sidoli A; Shelley CS; Lucero MA; Shoulders CC; Baralle FE
Nucleic Acids Res; 1984 May; 12(9):3917-32. PubMed ID: 6328445
[TBL] [Abstract][Full Text] [Related]
14. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
Cheung MC; Wolf AC; Illingworth DR
Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.
Greilberger J; Jürgens G
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):185-91. PubMed ID: 9512478
[TBL] [Abstract][Full Text] [Related]
16. Synthesis in vitro and translocation of apolipoprotein AI across microsomal vesicles.
Stoffel W; Blobel G; Walter P
Eur J Biochem; 1981 Dec; 120(3):519-22. PubMed ID: 6174327
[TBL] [Abstract][Full Text] [Related]
17. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma.
Nichols AV; Blanche PJ; Shore VG; Gong EL
Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles.
Hennessy LK; Kunitake ST; Kane JP
Biochemistry; 1993 Jun; 32(22):5759-65. PubMed ID: 8504094
[TBL] [Abstract][Full Text] [Related]
19. A serum proteinase converts proapolipoprotein AI secreted by rat hepatocytes to the mature apolipoprotein.
Stoffel W; Knyrim K; Bode C
Hoppe Seylers Z Physiol Chem; 1983 Nov; 364(11):1631-40. PubMed ID: 6420309
[TBL] [Abstract][Full Text] [Related]
20. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
Cheung MC; Mendez AJ; Wolf AC; Knopp RH
J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
